#Human Genetics Market size

[sp3ncer45]

Guess who decided to make a size chart mee I did

//MENTION OF ED/SH//

(CHANGES/HCS UNDER CUT)

||Keroro||

-He/him, cis, gay

-45(human years)

-He's short now like really short, I thought it would be cute

-a little bit chubby heart emoji

-He's got brown in his colors now(stole that from ziv❤)

-Claws!!!!!!

-Fuckass ushanka(Chip revvington reference I gave him a ushanka because of that FUCKASS chainsaw beast)

-I have a theory/headcanon that the keroro platoon was created and put together by keron hq to kind of be a "mascot platoon" with keroro being the somewhat offical mascot for the keron army, so like I wanted to make keroro look kind of cutesy like a marketable mascot. Hes not fully marketable here, his designs a little too complicated, but I imagine that keron has an altered version of keroro that's much closer to his original purpose that they use in tv and in products

||Tamama||

-He/She/They, genderfluid, likes men that's all I know

-15(human years)

-SHES TALLLLLL for a keronian atleast

-to be honest he changed the most out of all the others

-anyways they have much bulkier limbs now

-I wanted to make him look a little "manmade" with the colors on their body n the way shes built I suppose?? theres a reason for that

-Tamama is a clone, like dark keroro. I hc that on keron clones have to be genetically distinct from from non clone keronians so they can be identified as clones, like for example, their underbellies being dark colors as compared to the light colors of most keronians, and the lack of feet.

-Hes a clone of one of the very high ranking soldiers of the keron army. They were created as an experiment to test genetic mutations and making stable lifeforms with said mutations. He was raised by one of the scientists who was having issues having children of their own and so decided to take her in. Keron is surprisingly very open about their genetic testing and the fact they create manmade keronians, so tamama was allowed to live a pretty normal life and went to school n such.

-She has an ED where he will often binge large quantities of food and then purge for extended periods of time

||Giroro||

-He/him, cis(?), the most he will say is bi-curious (Hes mega gay)

-45(human years)

-Buff as hell

-is that a little bit of chub? or is it muscle belly? he won't tell you that's for sure

-I made his scar cooler

-his belt has multiple pictures of it, some of the cat, some of natsumi(NOT BC HE HAS A FUCKING CRUSH ON HER ITS BC HE CARES ABT HER LIKE A DAUGHTER I WILL KILL MYSELF OVER GIRONASTU AND NOT IN A GOOD WAY) but on the top is a picture of he and is family(garuru and his dad)

||Dororo||

-He/him, FTM, bisexual

-38(human years)

-Hes supposed to be canonically lean? no, fuck you, hes fat as hell actually

-Before coming to pekopon, he had a terrible ED, he would hardly eat or drink and this was mostly due to being psychologically abused by his mentor about being natrually plus-sized when he was training to be an assassin.

-When he came to pekopon, and became a ninja, he was able to overcome his ED and accept his body as it is. Realizing he was trans and transitioning helped a lot as well as the "ninja lifestyle".

-Also I hc that the time it took for him to reunite with the keroro platoon was significantly longer than how it was canonically (like 1 year), and when he reunited with the keroro platoon he was still struggling with body image issues relating to gender and weight. He was still in the middle of his journey of self-acceptance as well.

-Stretch marks bc I imagine that he gained a fairly large amount of weight in a short amount of time

-His hat drape thingy is much longer now(also stolen from ziv(hi ziv)) he treats it like hair sometimes

-some big ol long sharp claws❤(he likes to scratch things up like a cat, theirs a cat stretch pole at he and koyuki's place)

-Droopy eyes bc I think it makes him look silly

-PAW PADS!!!!!

||Kururu||

-He/they/ku, gender? I hardly know her, pansexual

-24(human years)

-Ku is chubby ❤ as he should be

-Hypersexual(that's from donnie hi donnie)

-SH scars from SH

-I imagine that they have quite a lot of self hatred issues and an inferiority complex. Ku hates to take care of himself bc he views themself as "undeserving" of care.

-The weird jerky uncaring asshole thing he has going on is mostly a shield so people won't see his true emotions, but also it's so people will hate him. In ku's mind if people hate him then they won't care about him, since he believes hes unworthy of it. It ends up being an toxic cycle, though, as he continues to keep up the jerk act, he believes hes more and more unworthy of love and care, so keeps it up, and so on and so forth.

EXTRA BITS:

-Kururu is the average height for civilian keronians, while dororo and giroro are around the height of soldier keronians. I hc that the keron army typically recruits taller keronians especially for on field stuff.

-I HC that keronians do croak, and keronians all have unique croaks. They typically croak when they are content, kind of like a purr but more casual. However in keronian society its considered rude to purr so most do it at home alone or with family. Croaking is kind of like a stim for keronians, they can do it as they please but sometimes they'll do it subconsciously as well

-speaking of purring keronians also purr. They purr when they feel good or are very happy. Unlike croaking they can't control purrs. What makes a keronian purr depends on the individual, sometimes a keronian has to feel really really good to purr sometimes a keronian will start purring at the drop of a dime lol

-Sometimes they knead like a cat but it's quite rare and only some do it.

(close ups of the characters)

[mariacallous]

There’s a well-established inverse relationship between a dog’s size and its expected lifespan. Bernese mountain dogs and Great Danes live just six to eight years, for example, while corgis can live up to 15 years and Chihuahuas up to two decades.

San Francisco biotech company Loyal wants to close that gap, and is developing an experimental drug to extend the lifespan and improve the quality of life of large and giant dog breeds. Today, the company announced that based on early data, the US Food and Drug Administration has determined that Loyal’s drug has a “reasonable expectation of effectiveness.” The company hasn’t yet shown that its drug actually extends lifespan, but the FDA decision signals the agency’s confidence in Loyal’s approach, and the drug will soon be tested in a bigger trial.

“Big dog owners want more time with their dogs,” says Loyal CEO Celine Halioua. “It’s really heartbreaking to people that they don’t live that long.” She argues that the wide variety in dog sizes isn’t natural, but a result of selective breeding by humans to create dogs with certain physical traits or that can perform specific tasks. On average, mixed-breed dogs live longer than their purebred counterparts.

So far, the FDA has not approved any drugs to expand the lifespan of animals—or humans, for that matter. “This is completely novel,” says Linda Rhodes, former CEO of pet biotech company Aratana Therapeutics and a consultant for Loyal. It’s difficult to study life-extension drugs in people, she says, because humans live relatively longer lives than other species. But starting with dogs—and the breeds with the shortest lives—could yield important clues. “The implication for other species, including humans, is pretty profound,” she says.

Loyal’s experimental drug is an injection designed to be given every three to six months by a veterinarian. The drug is meant to lower levels of a hormone called IGF-1, which is involved in growth and metabolism and has been linked to dog size. Large dogs have a genetic variant that leads to high levels of IGF-1 and small dogs have a different variant that results in lower levels.

Inhibiting this hormone has been shown to increase lifespan in worms, flies, and rodents. In humans, both very high and very low levels increase mortality risk, while a midrange is associated with the lowest mortality.

In early studies, Loyal dosed 130 research dogs with its investigational drug. Halioua says the company has shown that it can reduce IGF-1 levels in large dogs to those seen in medium-size dogs. Two dogs had loose stools for a day or two after receiving the injection, but beyond that, Halioua says, no major side effects have been observed.

To determine the drug’s effect on lifespan, the company is planning a bigger study that will start in 2024 or 2025, and enroll about 1,000 large and giant breed companion dogs that are at least 7 years old. Each will receive either the experimental drug or a placebo.

Halioua says the company aims to have its drug on the market by 2026. But first, Loyal still has to prove to the FDA—which regulates both human and veterinary medicines—that the injection is safe and that the drug can be reliably manufactured. At that point, the FDA can grant conditional approval, a temporary authorization that lasts five years and allows the drug to be sold by prescription. During that time, Loyal will collect effectiveness data and apply for full approval.

Loyal is also working on two other drugs: a pill version for large and giant dog breeds, and a pill for older dogs of all breeds.

Danika Bannasch, a veterinary geneticist at the University of California, Davis, who specializes in canine genetics, says that IGF-1 is only one factor thought to be associated with dog size and longevity. “As for targeting it, I think it’s a bit premature. We know that smaller breed dogs live longer than larger breed dogs, but we don’t know how much of that is due to the influence of IGF-1,” she says.

In a study published last month, Bannasch and her colleagues identified another possible driver of dog longevity, a gene called ERBB4. Studying more than 300 golden retrievers, they compared the DNA from blood samples of dogs that were still alive at 14 years of age to those that died before age 12. They found that dogs with certain variants of the gene survived longer—on average, 13.5 years compared to 11.6 years. Bannasch cautions that the work was conducted in only one breed and that it’s not known whether these variants are associated with longer life in other types of dogs.

The ERBB4 gene is the canine version of HER4, a human gene closely related to HER2, which is associated with cancer. Studying the canine gene could have implications for human health. Researchers are also testing new cancer treatments in dogs with the hope that these therapies could help people.

Giving an experimental drug to healthy dogs is different from treating sick dogs. Bannasch says Loyal’s drug will need to clear a high safety bar for owners to be comfortable giving it to their pets. She also thinks a drug would need to show more than a few months of life extension before people would want to buy it for their dogs. “As a pet owner, I think anything over a year would be great. I suspect people would be really interested in that,” she says.

Linda Rhodes says that humans owe it to dogs to make up for the genetic misfortunes they’ve inherited due to hundreds of years of breeding. “We’ve bred dogs to have problems because we want them to look or act a certain way,” she says. “It’s our responsibility to figure out how we can help.”

[sweetlikehoneystingslikeabee]

Killer Croc Backstory

Howdy, I got like three different asks about Killer Croc/Waylon Jones so we are going to delve into his background really quick for this blog for the sake of clarification. I'm taking less from the original "atavism" story since that genuinely isn't how that would work with a mammalian human and making it more about a genetic condition. Again, there's lots of different backstories for comic characters, this is just my personal take. Hope you enjoy!

Tw: child abuse/neglect, ableism, brief mention of cannibalism, murder, alcoholism

- Waylon was born a relatively "normal" child to Jean and Evangelique Jones in a small Louisiana town. They both noticed even as a baby he had this strange amber tint to those big brown eyes. Other than that and some scaly skin on his thighs, no one suspected there was anything particularly abnormal.

- Yet as he grew, more and more scales would appear on his skin. At first they matched the warm brown tone of his skin, but would start to turn green during puberty (when the scaling got out of control). His eyes became more yellow with each passing year of his life. When his teeth grew in, they were all sharp.

- It was determined to be a very rare genetic condition, passed down that skipped several generations. Waylons father left when it became apparent there was no cure. Despite being from a good sized family, none of them wanted anything to do with the child. In their small superstitious town, his mother was called a witch by some. That this was her punishment for not living a Godly life.

- This resulted in his mother being isolated in her community which turned inward and led to a lot of neglect, alcoholism, and dropping him off on his grandparents.

- some of his earliest real memories was listening to his grandmother Babette singing to him in French. He'd speak in whispered Cajun French to his grandfather James when they'd walk early morning markets hand in hand.

- For a long time they'd be the only ones to tell him the truth- that it was inherited. No one's fault and there's nothing "wrong" with him.

- great-great grandfather was actually similar to Waylon but not as tall. His grandmother would tell him she didn't know him well because he died young. Waylon would later find out he was murdered in his bed shortly after his son was born. His great grandfather had scales on his back he could hide and sharp nails he always cut back. Waylon was just unlucky in the genetic roulette.

- it wasn't surprising when Waylon found out about the murder. There were plenty of times other kids would get a hold of him alone and he himself thought he was going to die.

- Puberty was when he got big, his voice got gravelly, and the scales took over. By the time he was 15, 95% of his body was scaled over. He couldn't even grow hair on his head anymore, tight black curls replaced with almost bony ridges.

- Shortly after, he started fighting back with the bullies. One fight, he tore open another teenagers arm with his claws by accident, which resulted in his expulsion from school. He was spending less and less time with his grandparents due to his mother trying to "take control" of her son.

- She kicked him out at 17 to fend for himself and guilted him to not ask his grandparents for help. They didn't need "him around ruining their lives, too."

- It should be noted many years later, he and his mother made up and grew a relationship after a lot of healing, forgiveness and acknowledgement that how she treated him was wrong even if she was in a rough situation. He can call back home and talk to his grandparents (who now live with mom and her husband) in French for hours. But that's unfortunately much later in the timeline.

- He tried to find some hard labor jobs but nothing really stuck. Eventually, he got hired on as a wrestler for a traveling show. This is when he started drinking. For years he got used to the call of: "And in this corner, from the bayous of Louisiana- Killer Croc!"

- Genuinely it pissed him off no one even asked what he wanted to be called- "I told that couyon announcer there aren't even crocodiles in Louisianna!" But it stuck.

- even once he fell into crime. Wasn't hard, when you were barely making enough to survive. He ended up justifying a lot of horrible things he did as revenge for the way people treated him or as "just survival." He grew to like the taste of blood and picking people out of his teeth. The savagery. A more animalistic side of himself.

- Then it all just became a cycle. Drink, commit violence, go to prison or Arkham. Drink, commit violence, go to prison or Arkham. On a brief relapse he managed to get his GED in Arkham (Edward Nygma helped on threat of being eaten). Then it was drink, drink, commit violence and back where he started.

- it would take a while before he'd kick the alcohol and try to live a somewhat normal life. While he's perhaps not completely reformed in all aspects, he's very different than he once was and better for it.

[morphofan]

Travels With Tech: The WNC Farmer's Market/Garden Center

"Oh, Wrecker! You will like this. Hot sauce packaged in a container shaped like a primitive explosive device. It may even make our rations bars palatable."

"This 'cactus' is actually two different species of cactus. The colorful orb is one species, while the green stalk onto which it has been grafted, an entirely different species. I suppose it could be considered a very simple form of genetic manipulation."

"These are quite fascinating. Which reminds me, I should select a flower for Phee...."

"*Grunt* Well, this flower, while impressive, will likely prove too difficult to transport back to Pabu.

"Though it does provide a useful perch for reconnaissance, I will find a more suitable gift for Phee."

"This garden shop even has metal flowers."

"I have made an error in judgement and require assistance. Kindly extract me from this carnivorous plant before I am digested!"

"Ah! This will do nicely! The perfect size and color for Phee."

"My goodness, I never saw anything like this on Kamino. These fish are called 'Coy,' and apparently very expensive. I do not understand how a fish could be coy, as they lack brains advanced enough for human emotions."

"Ah! It is not 'coy,' but rather, 'Koi,' adapted from the regional name for 'carp.' The price of these fish can go well into the tens of thousands in the local currency. How intriguing. They must be considered a delicacy, to command such a high price. Perhaps I will get the opportunity to sample filet of 'Koi' before we leave the planet."

"Apologies, Madame, but on my home planet, fish are considered food, rather than Objets D'Art. The alerting of Security is unnecessary; you have my word as a soldier that I will not attempt to catch or cook your 'Koi'."

"We are waiting for Wrecker to decide which variety of hot sauce to purchase. I do wish I had my data pad...."

[savannahsdrabbles]

Ocean Song - Part 10.5

rating: PG

notes: 772 words. A03 link can be found here. Hi! I promise I'm/the story are not dead. This was originally going to be the intro to the final chapter, but I decided to share part now because I feel so bad about not posting :'D I have nearly 20 pages of the final chapter right now, so it should be coming soon!

***

Project Thrive’s initial goal had been simple enough; one of Japan’s biggest resources, seafood, was consistently in high demand. Local fishermen worked around the clock to provide for the nation and create a surplus large enough for exports, but were quickly becoming overwhelmed. Between the long, difficult shifts and heavy overfishing of prime locations, it was becoming increasingly more difficult to meet quotas.

Somewhere along the way, a necessary question was raised- was it possible to increase their resources without having to rely on international imports?

Enter Oroku Incorporated, one of the world’s top marine research facilities.

Under head scientist Baxter Stockman’s leadership, the company was commissioned to develop a process of bioengineering aquatic life to drastically increase their size and overall quality. If they were successful, one day’s catch could go further and allow relief for fishermen as well as giving the environment a chance to naturally repopulate.

Massive amounts of funding were poured into the project, and scientists immediately got to work.

Months passed and through a mixture of selective breeding and chemical cocktails, things slowly began to change. Squid, salmon, and other varieties of aquatic population began to quadruple, each generation proving to be bigger and stronger than the last. The market economy boomed, and other countries began to catch wind of what was happening.

More contracts were signed, alliances forged, and more money than they could count was dumped into Oroku’s lap.

Everything was going swimmingly, Baxter Stockman would often think to himself with an amused chuckle at his own wittiness.

Then one day, new orders came from Oroku Inc.’s government contacts in the form of an Agent John K. Bishop.

His rankings preceded him – dozens of degrees from top colleges, acclimations of praise from other members in the scientific community, and yet whenever Baxter Stockman attempted to dig deeper, he could never find anything about the man prior to the past ten years. It was almost as if he had popped into existence for such a time as this.

As soon as Bishop entered the scene, things began to change. Project Thrive continued, but its funding was divided and diverted towards a secondary focus. Oroku Incorporated had already proven that they could harness and bend genetics to their will - but just how much further could they push this?

Along with Bishop came a starting point supposedly provided by an anonymous donor– a psychotropic serum designed to separate the capacity for human-like cognition from the instinctual animal state. Stockman raised questions as to what this had to do with their goal, but the scornful responses he received made him hold his tongue.

Fish proved to be less than receptive to the new treatments- their bodies would convulse and swell grotesquely under the needle, mouths gaping as they let out high-pitched noises that sounded almost like screams. All died within hours of receiving a first dose.

Stockman had assumed that the laboratory would quickly draw the line there, refusing to continue the seemingly torturous experiments. However, to his surprise, the Board deferred to Bishop’s command and the experiments continued.

Months of failed attempts passed, and Bishop’s determination began to turn into a noticeable anxiety. Stockman caught him pacing in his office late at night more than once, muttering into a phone in strange tongues that he could only catch bits and pieces of. They were running low on the serum. The donor, whoever it was, was getting angry.

New animals were brought in.

Mammals.

Mice, rats, deer, rabbits. Anything in a desperate attempt to get the serum to work.

More breeding.

More tests run.

More deaths.

Then, slowly, progress.

A handful of creatures that survived the first dosage began to seem more alert. Their strength increased, as well as their cognitive abilities. Most still died within a few weeks, but it was clear that the scientists were moving in the right direction.

One night a lab rat received a larger dosage than usual and escaped from his cage. A fire soon broke out and by the time the flames had been doused, it and all of the other animals were either dead or unaccounted for.

Bishop silently exited the scene, gone as smoothly as he had entered, and Project Thrive was quietly archived as being too dangerous and expensive to pursue any further.

Baxter Stockman had assumed for years that any creature who escaped likely died within a few days as the serum continued to work its way through their veins.

That was until he suddenly received a fax and vials of DNA from Hamato Incorporated, containing traces of an element he never thought he would see again…

[ask-the-linked-systems]

Question for Pine: have you made a "world" for konazel? as in towns, states and continents

Well, there are two Konazels. Each is a planet. Konazel Major is about the size of Earth. Konazel Minor, which is really small, not much bigger than a moon, is the one that my stories take place on right now. This is why it's the only one I've really designed a landscape for. There are 3 continents, as well as many, many small islands.

One of the continents is polar, like Antarctica. It is called Cyrosika.

There is a continent called Itercika that no one really lives on. It's similar to Africa in climate, but after humans sent swarms of a deadly pest that they genetically manufactured called Herenos, Itercika was evacuated.

Finally, there is Mercika. It has a weird climate that is basically the USA but upside down (so the cold parts are in the southeast and the warm parts are in the northwest). Although there are no states, there are 6 zones, each of which governs itself. You can see the names of five zones on the map below. The sixth zone, Fondera, includes basically all the farmland and some wilderness.

Yes, I know I filled in all of Cindera with Suburban and all of Glomera with Urban. And yes, I now know that Urban doesn't necessarily mean city. Basically, the parts that I put Urban on are mainly cityscapes, with tall buildings, skyscrapers, and busy roads. Lemme just explain the zones. Just kinda ignore the color coding.

Glomera is like Manhattan. Packed to the brim with buildings. This is most evident in Central Glomera. North Glomera, especially the western part, is the rich snobs' part of the city. They all live there. Like, if you're rich, you probably live in either Bezian or Northwest Glomera. Southeast Glomera is a more residential area, kind of like Brooklyn. It has apartments and schools. Southwest Glomera is the slum/hood part. Also the manufacturing district.

Cindera is a bit like Southeast Glomera, except less busy. It is a great place to raise kids, which is in all of the advertisements for the neighborhoods there. The red dot is Market Square, which is the one part of the zone that is a cityscape. It's pretty small, though. The farther north you go of the Market Square, the more you get into the slum/hood. As you can see, Ash Avenue lies on the border of this. The military district is in the south. I also made a rough map of it, which is below. I didn't include everything, but it gives nearly enough information.

Also Pine why the frick is Market Square a trapezoid-

Mereta, which is mainly comprised of factories, is a bloody nightmare. The buildings are packed really close together, much, much more so than Glomera, but the people who built the city didn't use the square system, so you just have thin, winding alleyways, some that go all around the city, others that just hit a dead end and leave you cornered. Toss in the fact that there is no military district, and you have a recipe for a buttload of crime and chaos. Sable lived here when she was young, until her mother, Clementine, decided to move to Cindera, for her safety. Bezian is basically Las Vegas. Gambling. Drugs. Rich people. There is also a large island in the gulf which houses the main military base.

Minnowvera is kind of like Alaska. Not a lot of people live there, since Konazelians naturally dislike cold weather. The ones who do live there usually live in cabins or manors in the giant fricking forest. There are also a lot of people who settled near the big lake that I forgot the name of, which is located at the red dot.

[strangemusictriumph]

Organic Coffee Market - Forecast (2022-2027)

Organic Coffee Market size is estimated to reach $13.4 billion by 2027, growing at a CAGR of 8.3% during the forecast period 2022-2027. Coffee is one of the most popular beverages in the world, and the coffee bean is the second most traded commodity after petrol on the worldwide market. In more than 50 nations, more than 25 million farmers are involved in the production of coffee. Organic coffee is a popular beverage made without synthetic chemicals, pesticides, organic fertilizers, antibiotics, or growth hormones. Chlorogenic acid, fatty acids, flavanols, and catechins are amidst the numerous antioxidants discovered in them. The coffee beans utilized in the manufacturing of organic coffee are non-genetically modified organisms. Sustainability, renewable resources, and safeguarding the quality of the land, groundwater, and air are all priorities for the producers. Organic coffee has exploded in popularity in recent years, thanks to a shift in consumer preferences toward natural foods and sustainable lifestyles. One of the primary reasons driving market expansion is growing awareness of the advantages of organic foods and drinks throughout the world. Organic coffee has been shown to lessen cancer risk, lower cholesterol levels, increase immunity, aid weight reduction, and protect against neurological illnesses. It is also known to prevent large-scale cellular death by stabilizing damaging free radicals discovered in the human body. 

The health benefits of organic coffee including antioxidants and the growing trend of on-the-go coffee drinking are set to drive the Organic Coffee Market. The surging promotional operations on social media platforms and other platforms, like the internet, television, and newspapers, distributing knowledge about the benefits of organic food are set to propel the growth of the Organic Coffee Market during the forecast period 2022-2027. This represents the Organic Coffee Industry Outlook.

Request Sample

Report Coverage

The report: “Organic Coffee Market Forecast (2022-2027)", by Industry ARC covers an in-depth analysis of the following segments of the Organic Coffee Market.By Origin – Coffea Arabica and Coffea Canephora.

By Product Type – Fair Trade Coffee, Gourmet Coffee, Espresso Coffee, Coffee Pods and Others.By Roast – Light, Medium and Dark.

By Flavors - Chocolate And Caramel, Citrus And Floral, Almond, Amaretto, French Vanilla, Cinnamon and Others.By Packaging Type - Stand-Up Pouches, Jars & Bottles, and Others.

By Application - Food And Beverages, Pharmaceutical, Cosmetic And Personal Care and Others.By Distribution Channel - Hypermarkets/Supermarkets, Departmental And Convenience Stores, Specialty Stores, Online Sales Channels and Others.

By Geography - North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

Key Takeaways

Geographically, North America (Organic Coffee Market) accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the heightening processing and packaging in building the market for any brand and the soaring demand of specific coffee brands like Kona Coffee from the large island of Hawaii in the North American region.

Organic Coffee Market growth is being driven by the surging inclination of consumers towards organic beverages and the proliferating application of organic coffee in vegan baking, confectionery items, and personal care products. However, the heightening prices of organic food and beverages, soaring cost of production and operations, and shorter shelf life are some of the major factors hampering the growth of the Organic Coffee Market.

Organic Coffee Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Organic Coffee Market report.

Inquiry Before Buying

Organic Coffee Market Segment Analysis - By Application

The Organic Coffee Market based on the application can be further segmented into Food And Beverages, Pharmaceutical, Cosmetic and Personal Care, and Others. The Food And Beverages Segment held the largest market share in 2021. This growth is owing to the extensive application of organic coffee including antioxidants for confectionery and bakery products, direct intake, dairy products, smoothies, and shakes. With the quick adoption of western culture and expanding awareness of personal health, specifically among the younger generation in emerging countries, consumers are inclining more towards organic coffee including antioxidants. The kickoff of new organic coffee and coffee-associated assortments like cold coffee, cafe latte, and cappuccino appealing to an extensive audience is further propelling the growth of the Food And Beverages segment.

Furthermore, the Cosmetic And Personal Care segment is estimated to grow with the fastest CAGR of 9.8% during the forecast period 2022-2027 owing to the proliferating demand for organic flavored coffee in developed economies, the soaring development of cosmetic products including organic coffee with antioxidants and the surging awareness of the advantages of using coffee topically, like how it may help soothe, revitalize, cleanse, and smooth the skin.

Organic Coffee Market Segment Analysis - By Distribution Channel

The Organic Coffee Market based on distribution channels can be further segmented into Hypermarkets/Supermarkets, Departmental And Convenience Stores, Specialty Stores, Online Sales Channels, and Others. The Hypermarkets/Supermarkets Segment held the largest market share in 2021. This growth is owing to the supermarkets and hypermarkets being big retail shops that typically provide an assortment of retail product categories under one roof. In order to be accessible to clients, supermarkets are frequently placed near a residential neighborhoods. However, owing to a shortage of property near residential areas, the majority of supermarkets and hypermarket companies are expanding outside of the city. Walmart, Tesco, Aldi, Kroger, Carrefour, Whole Foods Market, and other major retailers have a substantial presence in the distribution of organic coffee. The shifting consumer tastes for low-calorie and sugar-free products have prompted many businesses to keep a surplus of organic coffee including antioxidants on hand which is further propelling the growth of this segment. 

Furthermore, the Departmental And Convenience Stores segment is estimated to grow with the fastest CAGR of 10.5% during the forecast period 2022-2027 owing to their low-volume purchase from manufacturers or suppliers, and smaller discounts typically offered by convenience stores when compared to hypermarkets, supermarkets, and internet businesses. 

Organic Coffee Market Segment Analysis - By Geography

The Organic Coffee Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Organic Coffee Market) held the largest share with 36% of the overall market in 2021. The growth of this region is owing to the rising demand for organic products, alterations in the dietary patterns, and growth of organic farming methods to cater to the demand for organic food attributed to the alarming rate of diseases in the North American region. The rising consumer awareness of the health benefits associated with the consumption of organic coffee including antioxidants over conventional coffee and Mexico, being one of the largest coffee-producing countries in the world, according to the National Coffee Association, U.S., are further propelling the growth of the Organic Coffee Market in the North American region.

Schedule a Call

Organic Coffee Market Drivers

Rise In The Consumption Of Healthy And Organic Foods Is Driving The Market Growth

The expansion of the organic coffee market is anticipated to be driven by an increase in the consumption of healthy and organic foods involving organic coffee including antioxidants, owing to the many advantages associated with these products. Synthetic and dangerous fertilizers, pesticides, herbicides, growth hormones, genetic engineering, artificial preservatives, flavors, and colors are not used in organic coffee manufacturing. The utilization of the USDA Organic seal signifies a product is at least 95 percent organic unless 100% organic is particularized. Coffee is a single-constituent product. Therefore, a bag of organic coffee is 100 percent organic beans. Organic drinks, according to Café Altura, an organic coffee business in the U.S., lower the risk of cardiovascular disease and heart failure, lower cholesterol, cut the risk of Type 2 diabetes, and boost the body's immunity. The rise in the consumption of healthy and organic foods is therefore fuelling the growth of the Organic Coffee Market during the forecast period 2022-2027.

Soaring Recognition Of Cafes Across The World Is Fuelling The Market Growth

Café culture and the habit of socializing at cafés has grown in popularity among urban youngsters. The rise in the number of food service outlets is being fuelled by an increase in the number of people moving to cities and a significant white-collar demographic. Various coffee shops, specialty coffee shops, and quick-service restaurants (QSRs) have sprung up to cater to various tastes and preferences for various varieties of fresh coffee. Coffee makers will have various branding options as the number of coffee-themed eateries grows. Consumers seek out premium coffee foods including antioxidants at coffee-themed eateries, prompting them to seek them out at retail outlets. Leading coffeehouse chains like Starbucks, Costa, and Barista are expanding into new markets. As per Coffee Shop Industry Statistics And Trends on brandongaille.com, the international business for these chains provide growth opportunities like Starbucks owning 5,500 international coffee shop locations. The increased recognition of malls and shopping centers has prompted players to make significant investments in coffee distribution through these venues. The soaring recognition of cafes across the world is therefore fuelling the growth of the Organic Coffee Market during the forecast period 2022-2027.

Buy Now

Organic Coffee Market Challenges

Prices Of The Raw Materials Are High Enough To Limit The Market Growth

The high cost of organic coffee is predicted to stifle the growth of the Organic Coffee Market in the forthcoming future. Organic coffee is typically 20% more expensive than ordinary coffee. Organic coffee is grown using natural fertilizers and pesticides, which raises the overall cost of production. Furthermore, the procedure of acquiring organic certification and inspection is expensive, resulting in an additional cost of roughly 10-15% higher than regular coffee. The expenses of certification and inspection are difficult to estimate since they are dependent on the kind and intensity of conventional farming techniques prior to conversion to organic agriculture. As a result, the high cost of manufacturing and certification raises the cost of organic coffee. These issues are hampering the growth of the Organic Coffee Market.

Organic Coffee Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Organic Coffee Market. The Organic Coffee top 10 companies are:

Complete Coffee Limited

Dr Pepper Snapple Group Inc. (Keurig Dr Pepper)

F S Gourmet Private Limited

Java Trading Co. LLC

Jim's Organic Coffee

Keurig Green Mountain, Inc.

Luigi Lavazza S.p.A.

Nestle S.A.

Rogers Family Company

Starbucks Corporation 

For more Food and Beverage Market reports, please click here

[detectivemaker]

hattercrow  horror au 3: little Hat Shop of Horrors

Jonathan panted slightly as with one final hard pull, he pulled the body bag down the final step to the basement, we caught his breath he threw the body into the center of the basement and gingerly walked over to it. He unzipped the bag to see list steel cooling corpse of a dentist that lived in the apartment complex next to the Haberdashery he worked at, the man's face was stuck in a Eternal rictus grin caused by the large amounts of laughing gas he inhaled causing him to suffocate on his own laughter, has Jonathan continued to pull the man's body out of the bag he thought of sweet sweet Harley and how better her life is going to be now that this waste of breath had finally died. Jonathan himself was not attracted to Harley but he really hated seeing her miserable with this man, plus Jonathan thanks Now that he's dead I finally got up food for the person I love

and almost like it heard his thoughts, a figure emerges from the Shadows of the basement, when it comes into the light the figure is much shorter than Jonathan and has a very kind face. The only thing odd about the figure is the three or four medium-sized red and white polka dotted mushrooms emerging from his hair, which is a ruby shade a red, when the Man's eyes look upon the corpse they begin to dilate was obvious hunger but before the man can do anything Jonathan begin speaking " now darling, you know you have to take off your clothes before you begin eating we don't want that nice shirt I bought for you getting stained" Jonathan points to the shirt the man is wearing which is a t-shirt that has a bunny with cordyceps mushrooms emerging from its forehead, Jonathan made this shirt for the creature that stands in front of him and would not like it getting stained," okay" the creature says with a pout as it begins removing the shirt and laying it gingerly on one of the chairs, the creature looks impatiently at Jonathan who gives a smirk and pushes the man over to the creature who was a smile opens his mouth to will be your two drawers filled with sharp teeth, I was a sickening squelch the creature begins to dig into it's meal

much later after the creature has been cleaned of the mess it made and put a shirt back on, it sits with Jonathan in front of the television watching gardening channels is Jonathan eats TV dinner the consist a lukewarm spaghetti, " so Cordy  you think of a new name for yourself" Jonathan asks the creature next to him, after a couple seconds of thought it gives an answer " I've been looking through this host bodies memories" the creature gestures to the body it inhabits " and I believe his name is Jarvis, so I'm going to take his name, you may refer to me as Jarvis". Jonathan looks at the creature now calling itself Jarvis and smiles,"  will Jarvis we won't have to worry about hiding you anymore seeing  as the host body you have is human and all we have to do to cover up the protrusions" Jonathan points to the mushrooms" is to get you a hat would you be easy to find seeing as you've nested yourself in the basement of a haberdashery i work at" Jonathan looks away from the creature for second before remembering something" that reminds me did you find that host body of yours" Jarvis thanks for a second before answering" I found him in an Alleyway, apparently he overdosed on something, it was pretty easy to worm my way into his brain cavity, but it did take a little bit of genetic fiddling to give him the right sort teeth needed for tearing into Flash, I put the old teeth in a jar for keepsake" Travis gets up on the couch and goes over to a shelf picking up a jar when it's brought over into the light of the television Jonathan can clearly see it's filled with teeth." cool" Jonathan says before  unpausing the TV and continuing to eat his lukewarm spaghetti

a couple years later Jonathan was having a talk with Harley," oh Johnny ever since jack disappeared my life just gotten better I put myself back on the love market and I found this very nice botanist lady with the most loveliest red hair, you should meet her Johnny she's the best" Harley pauses as she takes a swig of the Coco Jonathan made for her before continuing" speaking of love how Jarvis been" Jonathan takes a swig of his own Coco before answering" Jarvis and I have been doing good in our little home, you should really visit sometime Harley, is the greenest loveliest place two Lover's could ask for" Jonathan says with a sigh thinking of his favorite person in an apron making dinner for him," and guess what Harley" Jonathan says," what what Johnny what is it" Harley says a note supplies in her voice" me and Jarvis we had twins" Jonathan said letting out another dreamy side as he thought of watching his offspring sprouting their caps from the soil in the backyard feeding on the blood he spilled on the soil, as as darling spouse and  there eldest Offspring drink  glasses of blood," congratulations Johnny, I'll try to save up some money so me and Pam can come visit with a present for the kids" Harley say beaming as she finished her Coco and wait for Jonathan has he left and drove back to his beloved spouse, as Jonathan drove he pulled up to a homeless man and told him to get into the back, before long Jonathan was parked and pulling the man who he chloroformed on the way home into the basement to be drained of all of us blood, besides it was suppertime and as the man of the house he was duty-bound to get some food for his favorite fungi

[priyanshisingh]

Pet Food and Supplement Market Report: Opportunities and Challenges (2023-2032)

The Pet Food and Supplement Market is projected to grow from USD 119,095 million in 2024 to USD 185,563.87 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.70%.

The pet food and supplement market has experienced significant growth in recent years, driven by the increasing humanization of pets, where pet owners treat their animals as integral members of the family. This trend has led to a rising demand for high-quality, nutritious, and tailored pet food products that mirror the health and wellness trends seen in human food. Pet owners are now more informed and concerned about the ingredients in their pets' diets, seeking out foods that are not only palatable but also beneficial for their pets' overall health. As a result, the market has seen a surge in the availability of premium pet foods, including grain-free, organic, and natural formulations, as well as diets specifically designed to address health issues such as obesity, allergies, and digestive problems.

The growth of the pet food market is also closely linked to the increasing awareness of the specific nutritional needs of different pets based on factors such as age, breed, and activity level. For example, senior pets may require diets with joint-supporting supplements like glucosamine, while active or working dogs might benefit from higher protein content. This has led to the development of life-stage-specific and breed-specific formulas, catering to the unique requirements of pets at various stages of their lives. Moreover, the rise of personalized pet nutrition, where diets are tailored to the individual needs of a pet based on veterinary recommendations or genetic testing, is becoming a popular trend among pet owners who are willing to invest in customized solutions to ensure their pets' well-being.

In addition to pet food, the supplement market for pets is expanding rapidly, reflecting the growing interest in preventive health care and wellness for animals. Pet supplements, which include vitamins, minerals, probiotics, omega-3 fatty acids, and joint health products, are increasingly being used to support specific health concerns, such as joint mobility, coat health, digestive health, and immune system function. The popularity of supplements is driven by a combination of factors, including the aging pet population, the desire to manage chronic conditions naturally, and the influence of human health trends on pet care practices. For instance, the use of CBD supplements for pets has gained traction, particularly for managing anxiety, pain, and inflammation, mirroring the rise of CBD products in the human wellness market.

The pet food and supplement market is diverse, with a wide range of products designed to meet the specific needs of different pets. Here’s an overview of the main types of pet food and supplements:

Pet Food Types

Dry Food (Kibble):

Description: Dry food is one of the most common types of pet food, particularly for dogs and cats. It is shelf-stable, easy to store, and convenient to serve. Kibble is typically made by blending various ingredients into a dough, which is then baked or extruded into small, bite-sized pieces.

Benefits: Helps maintain dental health by reducing plaque and tartar buildup. It is also cost-effective and has a long shelf life.

Wet Food (Canned Food):

Description: Wet food is available in cans, pouches, or trays and has a higher moisture content than dry food. It is often more palatable to pets due to its softer texture and stronger aroma.

Benefits: Good for pets who need extra hydration, such as those with urinary tract issues. It is also easier to eat for pets with dental problems.

Semi-Moist Food:

Description: Semi-moist food falls between dry and wet food in terms of moisture content. It is usually packaged in pouches and has a soft, chewy texture.

Benefits: Convenient and easy to serve, often more appealing to picky eaters due to its texture and flavor.

Raw Food:

Description: Raw food diets, often referred to as BARF (Biologically Appropriate Raw Food) diets, consist of uncooked meat, bones, fruits, and vegetables. This diet aims to mimic the natural diet of wild animals.

Benefits: Proponents believe raw food diets offer better digestion, healthier skin and coat, and more energy. However, it requires careful preparation and handling to avoid contamination.

Freeze-Dried and Dehydrated Food:

Description: Freeze-dried and dehydrated foods are raw or cooked foods that have had the moisture removed to preserve them. They are often rehydrated with water before feeding.

Benefits: Offers the benefits of raw food with the convenience of dry food. It is lightweight, easy to store, and has a long shelf life.

Grain-Free Food:

Description: Grain-free food is formulated without common grains like wheat, corn, or rice, often using alternative carbohydrate sources such as potatoes or peas.

Benefits: Ideal for pets with grain allergies or sensitivities. It is believed by some to be closer to a pet's natural diet, although this is a topic of debate among veterinarians.

Prescription Diets:

Description: Prescription diets are specialized pet foods formulated to address specific health conditions, such as kidney disease, obesity, or gastrointestinal issues. These are usually recommended by veterinarians.

Benefits: Tailored nutrition that can help manage or improve certain health conditions in pets.

Organic and Natural Food:

Description: Organic pet food is made from ingredients that are grown without synthetic pesticides, fertilizers, or genetically modified organisms (GMOs). Natural food typically contains no artificial additives or preservatives.

Benefits: Perceived as healthier and safer, particularly for pets with sensitivities or owners who are concerned about artificial ingredients.

Homemade Pet Food:

Description: Homemade pet food is prepared by pet owners using fresh ingredients, often based on recipes formulated by veterinarians or pet nutritionists.

Benefits: Allows for complete control over ingredients, making it easier to tailor diets to specific health needs or preferences.

Pet Supplement Types

Vitamins and Minerals:

Description: Supplements that provide essential vitamins and minerals, such as vitamin A, B-complex vitamins, vitamin E, calcium, and zinc. These are often used to correct deficiencies or support overall health.

Benefits: Supports various bodily functions, including immune health, bone strength, and skin and coat health.

Joint Supplements:

Description: Common joint supplements include glucosamine, chondroitin, MSM (methylsulfonylmethane), and omega-3 fatty acids. These supplements are often used for pets with arthritis or joint pain.

Benefits: Helps maintain joint mobility, reduces inflammation, and supports cartilage health, particularly in aging or active pets.

Probiotics:

Description: Probiotics contain live beneficial bacteria that support gut health. They are available in powder, capsule, or chewable forms.

Benefits: Promotes a healthy digestive system, improves nutrient absorption, and helps manage gastrointestinal issues such as diarrhea or constipation.

Omega-3 and Fatty Acid Supplements:

Description: Omega-3 supplements, often derived from fish oil or flaxseed oil, provide essential fatty acids that are not typically produced by the pet’s body.

Benefits: Supports skin and coat health, reduces inflammation, and can help with heart health and cognitive function.

CBD and Calming Supplements:

Description: CBD supplements are derived from hemp and are used for their potential calming and anti-inflammatory effects. Other calming supplements may contain ingredients like L-theanine, chamomile, or valerian root.

Benefits: Helps manage anxiety, stress, and pain in pets, particularly in situations like thunderstorms, travel, or separation anxiety.

Antioxidant Supplements:

Description: These supplements contain antioxidants like vitamins C and E, selenium, and coenzyme Q10, which help neutralize free radicals in the body.

Benefits: Supports immune health, reduces oxidative stress, and may help in preventing chronic diseases such as cancer.

Digestive Enzymes:

Description: Digestive enzyme supplements help break down food more effectively, aiding in the digestion of proteins, fats, and carbohydrates.

Benefits: Supports digestive health, particularly in pets with pancreatic insufficiency or other digestive disorders.

Skin and Coat Supplements:

Description: These supplements often contain ingredients like biotin, omega-3 fatty acids, and zinc to promote healthy skin and a shiny coat.

Benefits: Helps reduce shedding, dandruff, and dry skin, contributing to a healthier appearance.

Immune System Support:

Description: Immune-boosting supplements may include ingredients like colostrum, beta-glucans, and echinacea, which are known to support the immune system.

Benefits: Enhances the pet's natural defenses against illness, particularly useful for pets recovering from illness or surgery.

Dental Supplements:

Description: Dental supplements include products like oral sprays, water additives, and chewables designed to support dental health.

Benefits: Helps reduce plaque and tartar buildup, freshens breath, and supports overall oral hygiene.

Key Player Analysis

Virbac

Pet Honesty

Nutramax Laboratories, Inc.

Mars, Incorporated

FoodScience Corporation

Zoetis, Inc.

Zesty Paws

Ark Naturals

NOW Foods

More About Report- https://www.credenceresearch.com/report/pet-food-and-supplement-market

The future outlook for the pet food and supplement market is highly promising, driven by several key trends and factors that are expected to shape the industry over the coming years. As pet ownership continues to rise globally, particularly in emerging markets, the demand for high-quality, nutritious, and tailored pet food and supplements is set to increase. Here’s a detailed look at the future outlook:

1. Continued Growth in Premium and Specialty Products

Humanization of Pets: The ongoing trend of pet humanization, where pets are increasingly viewed as family members, will continue to drive demand for premium and specialty pet food products. This includes organic, grain-free, and natural pet foods, as well as customized diets tailored to specific health needs or preferences. As pet owners seek to provide the best for their pets, the market for premium pet food is expected to grow significantly.

Personalized Nutrition: Advances in technology and nutrition science are enabling the development of personalized pet diets, based on factors such as age, breed, activity level, and even genetic makeup. The trend towards personalized nutrition, which is already gaining traction in the human food market, is likely to become a key growth area in pet food as well.

2. Expansion of the Pet Supplement Market

Health and Wellness Focus: Just as in human health, there is a growing focus on preventive care and wellness in pet health. This is driving the demand for pet supplements that support joint health, digestive health, skin and coat health, and overall immune function. The aging pet population, particularly in developed markets, will also contribute to the increasing use of supplements to manage age-related conditions.

Growth in Functional Supplements: The market for functional supplements, such as probiotics, omega-3 fatty acids, and CBD, is expected to expand as more pet owners seek natural and holistic solutions for their pets’ health issues. These products offer targeted benefits and are becoming an integral part of many pets’ daily routines.

3. Rise of Sustainable and Ethical Products

Environmental and Ethical Considerations: Sustainability and ethical sourcing are becoming increasingly important to pet owners. The demand for sustainably sourced ingredients, eco-friendly packaging, and transparency in supply chains will shape the future of the pet food and supplement market. Brands that prioritize sustainability and ethical practices are likely to attract a growing segment of eco-conscious consumers.

Alternative Proteins: The environmental impact of traditional meat production is leading to the exploration of alternative protein sources in pet food, such as plant-based proteins, insect-based proteins, and lab-grown meat. These alternatives not only address sustainability concerns but also appeal to pet owners looking for novel, nutritious options for their pets.

4. Technological Advancements and Innovation

Smart Feeding Solutions: Technology is playing an increasingly important role in pet care, with the development of smart feeders, automated dispensers, and mobile apps that track pets’ eating habits and health metrics. These innovations offer convenience and peace of mind to pet owners, while also providing data that can be used to refine and optimize pet diets.

Advanced Manufacturing and Quality Control: Innovations in food processing and quality control technologies will continue to improve the safety, nutritional value, and palatability of pet food and supplements. Enhanced traceability systems will also ensure that products meet the highest standards of safety and quality.

5. Growth in E-commerce and Direct-to-Consumer Models

Online Shopping Trends: The shift towards e-commerce, accelerated by the COVID-19 pandemic, is expected to continue shaping the pet food and supplement market. Online platforms provide consumers with a wide range of products, including niche and premium brands that may not be available in traditional retail stores. The convenience of home delivery, along with subscription services for regular supplies of pet food and supplements, will drive continued growth in online sales.

Direct-to-Consumer (DTC) Brands: DTC brands that offer customized, subscription-based pet food and supplements are gaining popularity. These brands often use data-driven approaches to personalize offerings and build direct relationships with consumers, allowing for better customer engagement and loyalty.

6. Expansion into Emerging Markets

Rising Pet Ownership: Emerging markets, particularly in Asia-Pacific and Latin America, are witnessing an increase in pet ownership due to rising disposable incomes, urbanization, and changing cultural attitudes towards pets. As a result, these regions are becoming important growth markets for pet food and supplements, with significant opportunities for both local and international brands.

Localization of Products: As brands expand into emerging markets, there will be a focus on localizing products to meet regional preferences and dietary needs. This includes formulating pet foods that cater to local tastes, dietary traditions, and nutritional requirements, as well as adapting marketing strategies to resonate with local consumers.

7. Increased Focus on Pet Health and Longevity

Preventive Healthcare: As pet owners become more aware of the impact of nutrition on their pets’ long-term health, there will be a growing emphasis on preventive healthcare through diet and supplements. Products that support longevity, enhance quality of life, and manage chronic conditions will be in high demand.

Veterinary Collaboration: The collaboration between pet food companies and veterinary professionals will likely strengthen, leading to the development of more scientifically backed, veterinary-recommended products. This collaboration will also help in educating pet owners about the benefits of tailored nutrition and supplements for their pets.

8. Challenges and Opportunities in Regulation

Regulatory Compliance: As the market for pet food and supplements grows, regulatory scrutiny is expected to increase, particularly concerning the safety, labeling, and marketing of products. Companies that proactively address these regulatory requirements, ensuring compliance and transparency, will build trust with consumers and gain a competitive edge.

Innovation within Regulation: The evolving regulatory landscape will also drive innovation as companies develop new products and formulations that meet or exceed regulatory standards. This includes the potential for new categories of supplements or fortified foods that address emerging health concerns in pets.

Segments:

Based on Pet:

Dog

Cat

Freshwater Fish

Others

Based on Application:

Multivitamins

Skin and Coat

Hip and Joint

Prebiotics and Probiotics

Calming

Others

Based on Source:

Organic

Conventional

Based on Distribution Channel:

Offline

Online

Browse the full report –  https://www.credenceresearch.com/report/pet-food-and-supplement-market

Browse Our Blog: https://www.linkedin.com/pulse/pet-food-supplement-market-analysis-global-industry-trends-beeqf

Contact Us:

Phone: +91 6232 49 3207

Email: sales@credenceresearch.com

Website: https://www.credenceresearch.com

[tamanna31]

New Trends of Oligonucleotide Synthesis Market with Industry Analysis by 2024 – 2030

Oligonucleotide Synthesis Industry Overview

The global oligonucleotide synthesis market size was estimated at USD 3.68 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.21% from 2024 to 2030. 

The decreasing prices of sequencing have led to increasing demand for custom-made nucleotides for applications across genetic testing, research, forensics applications, and drug development. This has further boosted the demand for oligonucleotide synthesis. The COVID-19 pandemic has affected every market globally and there has been a surge in the demand for efficient treatment against COVID-19.

Gather more insights about the market drivers, restrains and growth of the Oligonucleotide Synthesis Market

Oligonucleotide therapeutics hold immense potential for treating chronic conditions such as cardiovascular diseases, cancers, and retinal disorders. Emerging new applications of oligo sequences in multiple fields of biotechnology are expected to increase market growth. Demand for molecular diagnostics in precision care is an important emerging application field for oligonucleotide synthesis.

The introduction of advanced techniques such as CRISPR and high-throughput sequencing for gene expression analysis has simplified the genetic screening and modification of genomes. Such innovations are observed to influence the demand for oligonucleotide synthesis. Manufacturers invest in technology development to enable the production of long Oligonucleotides with higher precision and better yield to cater to the growing need for custom oligos.

The availability of a regulatory environment that supports the progress of genomics is the key factor contributing to the market growth. Changes in the regulatory policies to provide a well-framed environment for advanced biological research and application in human use are expected to influence demand for oligonucleotide synthesis significantly. Stem cells, regenerative medicine, genetic engineering, and synthetic biology are the prominent fields identified with high potential in healthcare. For instance, the International Society for Stem Cell Research (ISSCR) ethics and public policy committee aims to recognize and resolve issues by conducting open discussions. The committee includes experts in ethics, law, and social policy worldwide.

Browse through Grand View Research's Biotechnology Industry Research Reports.

The global optical genome mapping market size was valued at USD 104.1 million in 2023 and is expected to grow at a CAGR of 26.76% from 2024 to 2030. 

The global therapeutic drug monitoring market size was valued USD 1.80 billion in 2023 and is projected to grow at a CAGR of 3.8% from 2024 to 2030. 

Key Companies & Market Share Insights

Some of the key players operating in the market include Merck KGaA, Thermo Fisher Scientific, Inc., and Agilent Technologies. These players focus on business strategies such as partnerships/collaborations, product launches, and expansion. Twist Bioscience, Biolegio, and LGC Biosearch Technologies are some of the emerging market participants in the oligonucleotide market. These players primarily focus on expansion and partnerships to strengthen their position in the market.

Key Oligonucleotide Synthesis Companies:

·         Thermo Fisher Scientific, Inc.

·         Merck KGaA

·         Danaher Corporation

·         Dharmacon Inc.

·         Agilent Technologies

·         Bio-synthesis

·         Kaneka Eurogentec S.A

·         LGC Biosearch Technologies

·         Biolegio

·         Twist Bioscience

Recent Developments

In October 2023, IDT inaugurated a new therapeutic manufacturing facility to meet the increasing demand in genomic medicine. The new facility is equipped to support the production of therapeutic oligonucleotides, catering to the expanding needs in the field of genomics and personalized medicine.

In September 2023, Danaher Corporation (Integrated DNA Technologies) introduced a range of xGen NGS products tailored for the Ultima Genomics UG 100TM platform. The suite includes adapters, primers, and universal blockers, catering to various applications such as DNA, RNA, & methylation sequencing workflows. This offering is complemented by IDT's proven hybridization capture chemistry, enhancing versatility for researchers.

In July 2023, Analytix introduced two new instruments designed for organic synthesis, including wavePREP, tailored for oligonucleotide synthesis, and Xelsius, a workstation for multireaction synthesis.

In May 2023, GenScript expanded its life sciences facility in Zhenjiang, Jiangsu, China, to offer a rapid, high-purity oligonucleotide and peptide synthesis service tailored for research & development as well as preclinical applications.

In May 2023, Twist Bioscience and CeGaT GmbH launched the Twist Alliance CeGaT RNA Fusion Panel. This collaborative effort aims to provide a specialized tool for oncology research, facilitating the detection of RNA fusions and enabling transcript variant analysis. RNA fusions, a result of chromosomal arrangements often seen in cancers, can now be efficiently studied using this newly introduced panel.

In February 2023, Fluor Corp. and Agilent Technologies, Inc. collaborated to enhance its oligonucleotide therapeutics manufacturing facility in Frederick, Colorado. Under this collaboration, Fluor is expected to support the project's engineering and procurement. The total value of the project is evaluated at USD 725 million.

Order a free sample PDF of the Oligonucleotide Synthesis Market Intelligence Study, published by Grand View Research.

[ananya5400]

Biorational Pesticides Market Overview, Growth Factors, Opportunities, and Top Companies

The biorational pesticides market size is expected to expand from USD 7.5 billion in 2023 to USD 15.1 billion by 2028, with a compound annual growth rate (CAGR) of 15.2% during this period. Growing awareness of the harmful impacts of synthetic chemical pesticides on ecosystems, biodiversity, and human health has driven a shift toward more environmentally friendly alternatives. Regulatory authorities are increasingly supporting biorational pesticides due to their lower toxicity and reduced environmental persistence compared to synthetic chemicals, which is fueling market growth.

Biorational Pesticides Market Drivers: Government Initiatives on Chemical Pesticide Bans and Public Awareness Programs

The detrimental impact of chemical pesticides on soil, the environment, and water bodies globally has driven a growing focus on promoting biopesticides in agriculture. This push includes awareness campaigns and supportive policies that encourage private sector involvement. Regions like South America, Asia Pacific, and Europe are witnessing rapid market growth, thanks to initiatives that promote the use and production of biorational pesticides among farmers and producers.

In North America, the Environmental Protection Agency (EPA) regulates bioinsecticides, biofungicides, and bionematicides—key categories of biopesticides—overseeing their registration and monitoring their effects on human health and the environment. The sale and distribution of biopesticides are governed by the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), which ensures food and feed remain residue-free under the Federal Food, Drug, and Cosmetic Act (FFDCA).

In India, the government has integrated bioinsecticides into its Integrated Pest Management (IPM) approach, which combines cultural, mechanical, and biological pest control techniques. Central Integrated Pest Management Centers (CIPMCs) promote this strategy, along with the judicious use of chemical pesticides when necessary, through programs like Farmers Field Schools and training initiatives. These government efforts play a pivotal role in advancing the biorational pesticides market, especially bioinsecticides, by underscoring the importance of sustainable pest management practices.

Biorational Pesticides Market Opportunities: Advancements in microbial research undertaken by key players across regions

Companies like Bayer AG (Germany) have made significant advancements in microbial and RNA interference (RNAi) technology, creating promising opportunities in the biorational pesticides market. Major industry players in crop protection have invested heavily in research, leading to the use of biological signals to trigger RNAi-specific genes. This innovation has the potential to enhance disease and pest resistance while improving crop yield and quality. A key development is the focus on creating sprayable RNAi products for biological crop protection. For example, Monsanto Company (before its acquisition by Bayer) received EPA approval in 2017 for a genetic engineering technology that uses RNA interference to combat insect pests. Additionally, Corteva Agriscience (US) secured licenses for two insect traits from Monsanto, including an RNAi rootworm trait. The growing adoption of this technology in the industry offers a novel solution, especially for managing rootworm traits.

What are the key benefits of using microbials in biorational pesticide production?

The growth of the biorational pesticides market is driven by the use of microbials such as bacteria, fungi, viruses, and protozoa to create environmentally sustainable pest control solutions. These microorganisms work through specific modes of action, effectively targeting pests while reducing the impact on the environment and non-target species. They are formulated into various products, including microbial-based insecticides, fungicides, and nematicides.

For example, Bacillus thuringiensis (Bt), a well-known microbial insecticide, highlights the market's commitment to eco-friendly solutions. Bt produces insect-toxic proteins that specifically target certain pests without posing risks to humans, animals, or beneficial insects. Bt-based products, widely used in agriculture and mosquito control programs around the world, illustrate the market's shift toward sustainable pest management practices.

Asia Pacific's Biorational Pesticides Market Expected to Experience the Highest CAGR During the Forecast Period.

The Asia Pacific region is expected to experience the highest Compound Annual Growth Rate (CAGR) in the market from 2023 to 2028, driven by the increasing adoption of eco-friendly pest control solutions. Japan's "Organic Village" initiative, spearheaded by the Ministry of Agriculture, Forestry and Fisheries (MAFF), aims to boost the organic farming share to 25 percent by 2050. This initiative reflects a strategic push toward organic practices, likely fueling the demand for biorational pesticides in the region.

Similarly, China's “14th Five-Year Plan for National Economic and Social Development” underscores a growing focus on organic and sustainable agriculture. The plan highlights efforts to enhance green agricultural standards and strengthen certification for green food, organic products, and geographical indications. This commitment to eco-friendly farming is expected to increase demand for biorational pesticides in China, positively impacting the growth trajectory of the Asia Pacific market.

Top Biorational Pesticides Companies:

The key players in this include BASF SE (Germany), Bayer AG (Germany), UPL (India), FMC Corporation (US), Syngenta AG (Switzerland), Novozymes A/S (Denmark), Sumitomo Chemical Co., Ltd (Japan), Pro Farm Group Inc (US), Koppert (Netherlands), Valent BioSciences LLC (US), Gowan Company (US), Certis Biologicals (US), Biobest Group (Belgium), BIONEMA (UK), and Vestaron Corporation (US). 

Key Questions Addressed by the Biorational Pesticides Market Report:

Which are the major companies in the biorational pesticides market? What are their major strategies to strengthen their market presence?

What are the drivers and opportunities for the biorational pesticides market?

Which region is expected to hold the highest market share?

Which are the key technology trends prevailing in the biorational pesticides market?

What is the total CAGR expected to be recorded for the biorational pesticides market during 2023-2028?

Schedule a call with our Analysts to discuss your business needs:  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=57324225

[heathcareforallworld]

Lab Rat Market: Ethical Considerations, Advances, and Future Trends

Introduction

The use of lab rats in scientific research has been a fundamental practice for centuries. Lab rats are widely employed in a variety of research disciplines, including medicine, pharmacology, genetics, toxicology, and behavioral science. Their genetic similarities to humans, ease of handling, and breeding make them the preferred model for studying human diseases and evaluating the efficacy of new drugs.

As the global demand for advanced biomedical research grows, the lab rat market has seen significant expansion. This article delves into the current state of the lab rat market, exploring key factors driving growth, challenges faced by the industry, market segmentation, and future trends.

Market Overview

Lab Rat Market Size was estimated at 1.51 (USD Billion) in 2023. The Lab Rat Market Industry is expected to grow from 1.56(USD Billion) in 2024 to 2.1 (USD Billion) by 2032. The Lab Rat Market CAGR (growth rate) is expected to be around 3.76% during the forecast period (2024 - 2032).The increase in pharmaceutical research and development, particularly in areas like cancer, neurodegenerative diseases, and cardiovascular disorders, is driving the demand for lab rats. The focus on drug discovery and preclinical testing in these areas has increased the necessity for reliable animal models, with lab rats serving as an essential part of this process.

In addition to the pharmaceutical industry, academic institutions, contract research organizations (CROs), and biotechnology firms are significant contributors to the growing demand for lab rats. The market is further segmented by type, research application, and region, with technological advancements and ethical considerations shaping its future trajectory.

Key Drivers of the Lab Rat Market

1. Increased Biomedical Research

The most prominent driver of the lab rat market is the expanding scope of biomedical research. Lab rats have been instrumental in understanding human physiology and diseases, leading to the discovery of new treatments. Ongoing research into conditions like cancer, Alzheimer’s, diabetes, and genetic disorders relies heavily on lab rats due to their genetic similarity to humans and their well-documented biology.

2. Advancements in Genetic Engineering

Recent advancements in genetic engineering, particularly the development of transgenic and knockout rat models, have bolstered the use of lab rats in scientific research. These genetically modified rats are designed to mimic human disease conditions more accurately, allowing for more precise research and drug development. As demand for personalized medicine and precision therapeutics increases, so does the need for these genetically engineered rats.

3. Pharmaceutical and Biotechnology R&D

The global pharmaceutical industry’s heavy investment in research and development (R&D) is another key driver of the lab rat market. Preclinical testing using lab rats remains a critical step in evaluating the safety and efficacy of new drugs before they proceed to human trials. The rise of biologics, immunotherapies, and gene therapies in recent years has increased the need for reliable and relevant animal models, further driving the market.

4. Regulatory Requirements

Regulatory agencies like the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other global health bodies mandate preclinical testing on animal models before approving clinical trials on humans. Lab rats play a central role in this process, helping to ensure that new drugs and medical devices are safe and effective. This regulatory framework supports the continued demand for lab rats in research.

Market Segmentation

The lab rat market can be segmented into various categories based on:

Type: Common types of lab rats include Wistar rats, Sprague Dawley rats, Long-Evans rats, and genetically modified rats. Each type has specific applications in different fields of research.

Research Application: Lab rats are used in numerous research areas, including:

Drug discovery and development

Toxicology studies

Behavioral and neurological research

Genetic and molecular biology research

End Users: The primary end users of lab rats include academic institutions, pharmaceutical companies, biotechnology firms, and contract research organizations (CROs).

Challenges Facing the Lab Rat Market

1. Ethical Concerns

The use of lab animals, including rats, has long been the subject of ethical debate. Increasing concerns over animal welfare have led to stricter regulations and the development of alternative testing methods, such as in vitro and computational models. Many countries have implemented the "3Rs" principle (Replacement, Reduction, and Refinement) to minimize animal use in research, which could limit the growth of the lab rat market.

2. High Costs of Maintaining Animal Models

The cost of breeding, housing, and maintaining lab rats can be substantial, particularly for genetically modified strains. These costs, combined with the ethical challenges, have led some organizations to explore alternative research methods or to outsource animal research to regions with lower operating costs.

3. Emergence of Alternative Models

The advancement of alternative research models, such as organ-on-chip technologies and human stem cell research, poses a potential challenge to the lab rat market. These alternatives can replicate human tissue responses more accurately in some cases, reducing the need for animal models.

Regional Insights

The lab rat market is dominated by North America, followed by Europe, owing to the high concentration of pharmaceutical companies and academic research institutions in these regions. North America's market dominance is largely driven by the U.S., which is home to several global research hubs and major pharmaceutical firms.

Europe is also a significant market for lab rats, with strong demand from countries like the U.K., Germany, and France. These regions have a high level of government support for research and development in the pharmaceutical and biotechnology sectors.

In the Asia-Pacific region, the lab rat market is growing rapidly, driven by increasing investments in pharmaceutical R&D, particularly in countries like China, India, and Japan. The region’s cost advantages and expanding research infrastructure make it an attractive hub for outsourcing preclinical studies.

Future Outlook

Despite the challenges posed by ethical concerns and the rise of alternative models, the lab rat market is expected to grow steadily in the coming years. The ongoing expansion of biomedical research, combined with technological advancements in genetic engineering and the growing demand for personalized medicine, will continue to drive demand for lab rats in preclinical studies.

Moreover, as regulatory requirements remain stringent, lab rats will continue to be a crucial part of drug discovery and development processes. Innovations in the refinement of animal models and research practices, coupled with advancements in genetic technologies, will ensure that lab rats remain a key component of scientific research for the foreseeable future.

Conclusion

The lab rat market plays a vital role in the advancement of biomedical research, particularly in drug discovery and development. While ethical concerns and the emergence of alternative models present challenges, the market is poised for growth due to increasing demand from the pharmaceutical and biotechnology sectors. With ongoing innovations and investments in research, the lab rat market will continue to evolve, supporting crucial breakthroughs in medical science.

[marketresearchintent]

Human Augmentation Market: Exploring the Impact on Healthcare and Beyond

Introduction

Human augmentation, the fusion of human abilities with cutting-edge technology, is not just a concept out of science fiction; it's a rapidly growing industry. As technology continues to advance at an unprecedented rate, the boundaries of what it means to be human are expanding. From wearable devices that monitor our health to genetic modifications that could eliminate diseases, human augmentation is poised to revolutionize various aspects of our lives. The market for human augmentation is expected to surge from USD 171.4 billion in 2023 to a staggering USD 719.7 billion by 2030, reflecting a compound annual growth rate (CAGR) of 22.8% during this period.

Market Size and Growth Projections

The human augmentation market is currently valued at USD 171.4 billion in 2023. This market has been growing steadily, driven by advancements in technology, increased consumer interest, and the rising demand for enhanced human capabilities. By 2030, the market is projected to reach USD 719.7 billion. This growth is attributed to several key factors:

Technological Advancements: Continuous innovation in wearable and implantable devices, genetic engineering, and bionics is driving market expansion.

Increasing Healthcare Needs: As the global population ages, there is a growing demand for medical solutions that enhance human capabilities, such as advanced prosthetics and exoskeletons.

Military and Defense Applications: Governments are increasingly investing in human augmentation technologies for military purposes, including enhanced physical abilities and cognitive functions.

However, the market also faces challenges, including high costs, regulatory hurdles, and ethical concerns surrounding the modification of human abilities.

Download Sample Report @ https://intentmarketresearch.com/request-sample/human-augmentation-market-3025.html 

Key Technologies in Human Augmentation

Wearable Devices

Smartwatches and Fitness Trackers: These devices have become mainstream, offering real-time health monitoring and fitness tracking. They represent the entry point into the world of human augmentation, with their ability to track vital signs, monitor sleep patterns, and provide personalized health insights.

Augmented Reality Glasses: AR glasses are set to transform the way we interact with the digital world, overlaying information directly onto our field of view. These glasses have applications in gaming, healthcare, and even in industrial settings where hands-free information access is crucial.

Implantable Devices

Neural Implants: These devices, often referred to as brain-computer interfaces (BCIs), have the potential to revolutionize the treatment of neurological disorders. They also open the door to advanced human-machine integration, allowing for direct control of devices through thought alone.

Biochips: These tiny devices can be implanted under the skin to monitor various biological processes. Biochips are being developed for use in personalized medicine, where they can provide real-time data on an individual's health status.

Genetic Augmentation

CRISPR Technology: CRISPR is a groundbreaking genetic editing technology that allows for precise modifications to DNA. It holds the promise of curing genetic diseases and even enhancing certain human traits.

Gene Therapy: This approach involves altering the genes within a patient's cells to treat or prevent disease. Gene therapy is still in its early stages but has shown promise in treating conditions like blindness and certain cancers.

Bionics and Prosthetics

Advanced Prosthetic Limbs: Modern prosthetics are becoming increasingly sophisticated, offering greater dexterity and control. These devices are often integrated with the user's nervous system, allowing for natural movement and feedback.

Exoskeletons: Originally developed for military use, exoskeletons are now being adapted for civilian applications, particularly in healthcare. They can assist individuals with mobility impairments, allowing them to walk and perform tasks they would otherwise be unable to do.

Access Full Report @ https://intentmarketresearch.com/latest-reports/human-augmentation-market-3025.html 

Market Segmentation

The human augmentation market can be segmented in several ways:

By Product Type: Wearable devices, implantable devices, genetic augmentation, and bionics.

By Application: Healthcare, military and defense, consumer electronics, and industrial applications.

By End-User: Hospitals, military organizations, research institutions, and individual consumers.

By Region: North America, Europe, Asia-Pacific, and the Rest of the World.

Leading Companies in the Human Augmentation Market

Key Players Overview

ABB, Alphabet, Apple, Boston Dynamics, Cyberdyne, Ekso Bionics, Fanuc, KUKA, Magic Leap, NEC, Samsung

Impact of Human Augmentation on Various Sectors

Healthcare

Human augmentation technologies are revolutionizing healthcare by providing new ways to treat chronic conditions, improve patient outcomes, and enhance the quality of life for individuals with disabilities.

Military and Defense

The military sector is one of the largest investors in human augmentation. Technologies such as exoskeletons and neural implants are being developed to enhance the physical and cognitive abilities of soldiers.

Consumer Electronics

Wearable devices like smartwatches and AR glasses are driving growth in the consumer electronics sector. These products are becoming increasingly popular among consumers looking for ways to enhance their daily lives.

Industrial Applications

In industrial settings, human augmentation technologies are improving worker safety and productivity. Exoskeletons, for example, are being used to reduce the physical strain on workers, leading to fewer injuries and greater efficiency.

Regulatory and Ethical Considerations

Regulatory Landscape

The rapid advancement of human augmentation technologies presents challenges for regulators. Ensuring the safety and efficacy of these products is paramount, but the regulatory landscape is still evolving.

Ethical Challenges and Considerations

Human augmentation raises significant ethical questions, particularly around the potential for inequality, privacy concerns, and the modification of human traits. These issues must be carefully considered as the market continues to grow.

Investment Opportunities in Human Augmentation

Current Investment Trends

Investors are showing increasing interest in human augmentation, particularly in companies developing wearable devices and genetic technologies. Venture capital is flowing into startups that are pushing the boundaries of what human augmentation can achieve.

Future Opportunities

As the market matures, there will be significant opportunities for investment in areas like personalized medicine, advanced prosthetics, and consumer electronics. Companies that can navigate the regulatory and ethical challenges while continuing to innovate will be well-positioned for growth.

Future Trends in Human Augmentation

The future of human augmentation is bright, with numerous technological innovations on the horizon. Emerging applications include brain-computer interfaces, advanced gene editing techniques, and the integration of artificial intelligence with human capabilities.

Conclusion

The human augmentation market is on the cusp of a major expansion, driven by technological advancements and increasing demand across various sectors. As we look to the future, the potential for human augmentation to transform our lives is immense. However, with this potential comes the need to address the regulatory and ethical challenges that accompany such profound changes.

FAQs

What is the Human Augmentation Market? The human augmentation market involves technologies that enhance human capabilities, such as wearable devices, genetic modifications, and bionic limbs.

What are the key drivers of market growth? Key drivers include technological advancements, increasing healthcare needs, and military applications.

How are ethical issues being addressed? Ethical issues are being addressed through ongoing dialogue among stakeholders, including regulators, companies, and ethicists, to ensure responsible development and use of these technologies.

What sectors will benefit most from human augmentation? Healthcare, military and defense, consumer electronics, and industrial applications are the primary sectors benefiting from human augmentation.

How can businesses invest in this market? Businesses can invest by focusing on innovation, partnering with research institutions, and navigating the regulatory landscape to bring new products to market.

[industryforecastnews]

Induced Pluripotent Stem Cells Production Market To Reach USD 2.76 Billion By 2030

Induced Pluripotent Stem Cells Production Market Growth & Trends

The global induced pluripotent stem cells production market size is expected to reach USD 2.76 billion by 2030, registering a CAGR of 9.44% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increase in demand for induced pluripotent stem cells (iPSCs) in comparison to Embryonic Stem Cells (ESCs) has offered a significant drive to the market. Advantages such as no stem cell-related ethical issues, personalized treatment, and flexibility during cell-based research have created a favorable scenario for market growth. In addition, the prevalence of chronic disorders is also driving the growth of the induced pluripotent stem cells production market, as conditions like heart disease, stroke, diabetes, and many more can be treated by utilizing iPSCs-mediated therapy. For example, according to the International Diabetes Federation (IDF), 537 million people are already living with diabetes in 2021.

The rising research activities during COVID-19 pandemic have positively impacted the market. The pandemic fueled research in many fields as the SARS CoV-2 infection resulted in many diseases in the patients. For instance, in April 2021, researchers from USA stated that up to 25% of COVID-19 patients suffered cardiac dysfunction. Through their research article, they demonstrated the pathogenesis via exposure of iPSCs-derived cardiac cells to SARS CoV-2, and similar alterations were confirmed from human autopsy specimens of the patients. Such insights allow the use of induced pluripotent stem cells (iPSCs) as drug or therapy development platforms and their utilization in the management of the long-term effects of COVID-19.

Induced pluripotent stem cells are cells that are derived from adult somatic cells and then further reprogrammed to obtain the pluripotency as that of ESCs. These iPSCs are proving to be an ethically uncomplicated alternative for research that involves ESCs. The derivation of the ESCs is associated with the destruction of an embryo at the blastocyte stage, which has led to a maximum number of ethical debates. However, induced pluripotent stem cells have solved the ethical issue over the destruction of human embryos in research by involving only the genetic reprogramming of somatic cells. This has propelled the market growth and resulted in numerous applications including drug discovery, disease modeling, toxicology testing, and many others. For instance, in August 2021, Fate Therapeutics announced the treatment of the first patient with FT819 during clinical trials. FT819 is an engineered CAR-T cell therapy that is derived from iPSCs. Also, the rising focus of the research community on exploring applications of induced pluripotent stem cells in regenerative medicine due to their unique characteristics such as differential potential, self-renewable, immunomodulatory properties, and others; is set to drive the market expansion.

Request a free sample copy or view the report summary: https://www.grandviewresearch.com/industry-analysis/induced-pluripotent-stem-cells-production-market-report

Induced Pluripotent Stem Cells Production Market Report Highlights

By process, the manual iPSC production process segment dominated the market and accounted for the largest revenue share in 2023.

By workflow, the cell culture segment dominated the market with the largest revenue share of 37.34% in 2023. Cell culture workflow is inclusive of revenues generated from iPSC harvest products, expansion products, and differentiation products; thus contributing to the market relevance of this segment.

By product, the consumables and kits segment dominated the market and accounted for the largest revenue share of 40.32% in 2023. The never-ceasing research and development activities in the iPSCs space are driving the demand for various consumables & kits.

By application, drug development & discovery segment dominated the market with the largest revenue share of 43.33% in 2023.

By end-user, the biotechnology and pharmaceutical companies segment dominated the market with the largest revenue share of 59.35% in 2023. The availability and adoption of various kits, consumables, and instruments along with iPSCs products are driving the revenue generation in this segment.

North America dominated the market and accounted for the largest revenue share of 40.98% in 2023. The growing incidence of chronic diseases in this region, developed healthcare infrastructure, funds from private & government initiatives, and strategic business models are driving the revenue generation in the marketspace. 

Induced Pluripotent Stem Cells Production Market Segmentation

Grand View Research has segmented the global induced pluripotent stem cells production market based on process, workflow, product, application, end-use, and region:

Induced Pluripotent Stem Cells Production Process Outlook (Revenue, USD Million, 2018 - 2030)

Manual iPSC Production Process

Automated iPSC Production Process

Induced Pluripotent Stem Cells Production Workflow Outlook (Revenue, USD Million, 2018 - 2030)

Reprogramming

Cell Culture

Cell Characterization/Analysis

Engineering

Others

Induced Pluripotent Stem Cells Production Product Outlook (Revenue, USD Million, 2018 - 2030)

Instruments/ Devices

Automated Platforms

Consumables & Kits

Media

Kits

Others

Services

Induced Pluripotent Stem Cells Production Application Outlook (Revenue, USD Million, 2018 - 2030)

Drug Development & Discovery

Regenerative Medicine

Toxicology Studies

Others

Induced Pluripotent Stem Cells Production End-use Outlook (Revenue, USD Million, 2018 - 2030)

Research & Academic Institutes

Biotechnology & Pharmaceutical Companies

Hospitals & Clinics

Induced Pluripotent Stem Cells Production Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

Thailand

South Korea

Latin America

Brazil

Argentina

Middle East and Africa (MEA)

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players in Induced Pluripotent Stem Cells Production Market

Lonza

Axol Bioscience Ltd.

Evotec

Hitachi, Ltd.

REPROCELL Inc.

Merck KGaA

REPROCELLS, Inc.

Fate Therapeutics

Thermo Fisher Scientific, Inc.

StemCellsFactory III

Applied StemCells, Inc.

Browse Full Report: https://www.grandviewresearch.com/industry-analysis/induced-pluripotent-stem-cells-production-market-report

[market-insider]

Veterinary Clinical Trials Market Future Outlook: Analyzing Size, Share, and Growth Patterns

The global veterinary clinical trials market size is expected to reach USD 8.99 billion by 2030, exhibiting a CAGR of 9.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. The key factors driving industry growth include increased R&D expenditure by key players, rising prevalence of chronic diseases in animals, advancements in veterinary medicines, and rise in strategic alliances. For instance, in April 2024, Boehringer Ingelheim, a biopharmaceutical company focused on both human and animal health invested USD 593.5 Mn in animal health R&D to accelerate veterinary clinical trials as well as to develop innovative veterinary medicine.

Veterinary Clinical Trials Market Report Highlights

Ongoing advancements in veterinary medicine drive the demand for veterinary clinical trials to improve animal health and welfare. Additionally, growing R&D investments by key players to innovate veterinary medicine are expected to boost market demand.

By animal type,companion animal segment dominated the market in 2023 and is projected to witness the fastest growth rate of 9.5% in the coming years. Furthermore, among companion animals, canines segment is holding highest market share in 2023.

In terms of indication, oncology segment dominated the market with a share of 27.51% in 2023, owing to the rising prevalence of cancers in animals and growing R&D investment for veterinary oncology. Whereas internal medicine segment is expected to grow at the fastest rate of over 10.2% in the coming years.

Based on the sponsor, pharmaceutical and biopharmaceutical companies segment dominated the market in 2023, and the academics and research centers segment is expected to grow at the fastest rate of over 9.8% in the coming years.

Medicines accounted for the largest market share by intervention type in 2023. However, medical device segment is estimated to witness the highest growth rate of around 10.0% in the near future.

In 2023, North America held the highest share of 33.70% of the market by region.The Asia Pacific region is expected to grow at the fastest rate of over 10.1% in the coming years.

For More Details or Sample Copy please visit link @: Veterinary Clinical Trials Market Report

Additionally, an increasing number of clinical trials for rare diseases in pets is expected to drive veterinary clinical trial market. Veterinary clinics and research institutions are undertaking specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques designed for individual dogs' genetic profiles. For instance, in March 2024, Vivesto AB initiated its Paccal Vet clinical trial for dogs with splenic hemangiosarcoma, marking a significant step toward addressing this challenging cancer type in canines. The trial aims to assess the safety and efficacy of Paccal Vet, formulated with XR-17 technology, with promising results potentially leading to further pivotal studies.

There is a growing focus on preventive care in veterinary medicine. Clinical trials aimed at developing preventive treatments, such as vaccines and early diagnostic tools, are becoming more common. Furthermore, veterinary clinics and research institutions are launching specialized clinical trial initiatives focused specifically on rare canine cancers. These trials aim to investigate novel treatment approaches, including targeted therapies, immunotherapies, and precision medicine techniques tailored to individual dogs' genetic profiles.

List of Key Players in the Veterinary Clinical Trials Market

Charles River Laboratory

IDEXX Laboratories, Inc.

Boehringer Ingelheim International GmbH.

Argenta

Bioagile Therapeutics Pvt. Ltd.

Veterinary Research Management

Merck & Co., Inc.

Labcorp Drug Development

OCR - Oncovet Clinical Research

Vivesto AB

Vetbiolix

[trendingreportz]

Metagenomics Market - Forecast(2024 - 2030)

Metagenomics Market Overview

Metagenomics Market size is estimated to reach $1.5 billion by 2027, growing at a CAGR of 16.2% during the forecast period 2022-2027. Metagenomics is the examination of genetic material reclaimed directly from environmental samples. The expansive field may also be specified as environmental genomics, eco-genomics or community genomics. Shotgun metagenomic sequencing is a comparatively novel environmental sequencing technique utilized to analyze thousands of organisms in parallel and completely sample all genes, offering acumen into community biodiversity and function. 16S rRNA gene sequencing is typically restricted to recognizing bacteria at the genus level (e.g. Bifidobacteria). De novo assembly has been a necessary instrument in current investigations in metagenomics viral analysis. Glycoside hydrolases (GHs) are amidst the industrially significant enzymes that are widely explored by way of metagenomics owing to their very great expedience and significance in food and additional industrial sectors. Whole-genome sequencing offers added information on the nature and localization of antimicrobial resistance factors and on their dissemination possibility by horizontal gene delivery, and on genes connecting to virulence and biological fitness. Interoperable data will play a principal role in the forthcoming utilization of whole genome sequencing and metagenomic data.

The COVID-19 pandemic is set to drive the Metagenomics Market owing to the extensive utilization of technologies like Metagenomics in pandemic hazard computations to detect the molecular alterations in pathogens at the time of their worldwide rise, which could help in the forecast of rising hotspots, populations at risk, and the pathogens under genetic evolution as per the research article issued in Future Science, 2021. The burgeoning interest of researchers in related new research fields like metatranscriptomics, metaproteomics, and metabolomics has inspired microbiologists to investigate related workflows` in conjunction with novel techniques like shotgun metagenomic sequencing and is set to propel the growth of the Metagenomics Market during the forecast period 2022-2027. This represents the Metagenomics Industry Outlook.

Report Coverage

The report: “Metagenomics Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Metagenomics Market.

By Product: Sequencing And Data Analytics Services, Kits And Reagents, Others. By Technology: Sequencing Driven, Function Driven. By Application: Human Health, Environmental, Others. By Geography: North America (the U.S, Canada, and Mexico), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), Europe (Germany, France, UK, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), and Rest Of The World (Middle East, Africa). 

Request Sample

Key Takeaways

Geographically, North America Metagenomics Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the existence of a soaring count of pharmaceutical and biotechnological firms developing new and effective metagenomic platforms in conjunction with novel techniques like shotgun metagenomic sequencing in the North American region.

Metagenomics Market growth is being driven by the technological advancements in DNA sequencing in conjunction with the development of novel techniques like shotgun metagenomic sequencing. However, the soaring cost of complete metagenomics is one of the major factors hampering the growth of the Metagenomics Market.

Metagenomics Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Metagenomics Market report. 

Metagenomics Market Segment Analysis – By Product:

The Metagenomics Market based on products can be further segmented into Sequencing And Data Analytics Services, Kits And Reagents, and Others. The Kits And Reagents Segment held the largest market share in 2021. This growth is owing to the considerable count of kits and reagents being introduced and utilized to back the increasing demand for library preparation workflows from research laboratories. The boost in the rate of application and the great infiltration in conjunction with the extensive application of shotgun metagenomic sequencing is further propelling the growth of the genome engineering segment.

Furthermore, the Sequencing And Data Analytics Services segment is estimated to grow with the fastest CAGR of 16.9% during the forecast period 2022-2027 owing to the accelerated and considerable cost minimization in next-generation sequencing which has productively expedited the growth of sequence-based metagenomics in conjunction with the soaring application of shotgun metagenomic sequencing.

Inquiry Before Buying

Metagenomics Market Segment Analysis – By Technology:

The Metagenomics Market based on technology can be further segmented into Sequencing Driven and Function Driven. The Sequencing Driven Segment held the largest market share in 2021. This growth is owing to the soaring application of this technology. The burgeoning acceptance of this technology may be ascribed to the onset of new bioinformatics-associated solutions, which make workflows easy and offers accelerated outcomes. shotgun metagenomic sequencing permits researchers to exhaustively sample all genes in all organisms existing in a given complex sample. Surging endeavors to keep up a standard database and increase in the count of metagenome samples accumulated at data repositories are further propelling the growth of this segment.

Furthermore, the Function Driven segment is estimated to grow with the fastest CAGR of 17.1% during the forecast period 2022-2027 owing to the increasing application of function-driven metagenomics for protein screening applied to antibiotic resistance and vitamin manufacture in conjunction with the proliferating application of shotgun metagenomic sequencing.

Metagenomics Market Segment Analysis – By Geography:

The Metagenomics Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America (Metagenomics Market) held the largest share with 36% of the overall market in 2021. The growth of this region is owing to the surging spend on R&D. The extensive acceptance of metagenomic diagnostic, an expanding count of next-generation sequencing(NGS) based research endeavors in conjunction with increased application of shotgun metagenomic sequencing and the existence of key players like Illumina Inc., in the region are propelling the growth of the Metagenomics market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like consistent developments performed to build up the bioinformatics infrastructure and genomic landscape in nations like India and China. The considerable fluctuation in climate and environment in the region together with the heightening application of shotgun metagenomic sequencing is fuelling the progress of the Metagenomics market in the Asia-Pacific region.

Schedule a Call

Metagenomics Market Drivers

Increased Application Of Shotgun Metagenomic Sequencing Is Projected To Drive The Growth Of Metagenomics Market:

Shotgun metagenomic sequencing developed by Illumina Inc., permits researchers to completely sample all genes in all organisms existing in a given complex sample. The technique allows microbiologists to assess bacterial diversity and discover the profusion of microbes in different environments. Shotgun metagenomics also offers a means to investigate unculturable microorganisms that are otherwise hard or impossible to evaluate. Unlike capillary sequencing or PCR-based techniques, next-generation sequencing (NGS) permits researchers to sequence thousands of organisms in parallel. With the capability to integrate abundant samples in a single sequencing run and acquire high sequence coverage per sample, NGS-based metagenomic sequencing can discover very low abundance members of the microbial community that may be unnoticed or are too high-priced to recognize utilizing additional techniques. The surging application of shotgun metagenomic sequencing is fuelling the growth of the Metagenomics Market during the forecast period 2022-2027.

Benefits Of 16S rRNA Sequencing Are Expected To Boost The Demand Of Metagenomics:

16S rRNA Sequencing is a typical amplicon sequencing technique utilized to recognize and compare bacteria existing within a given sample. The prokaryotic 16S rRNA gene is almost 1500 bp long, with nine variable regions integrated between conserved regions. Variable regions of the 16S rRNA gene are generally utilized for the phylogenetic classification of genus or species in different microbial populations. An essential advantage of 16S rRNA Sequencing is that it offers an affordable method to recognize strains that may not be discovered utilizing conventional techniques. Unlike capillary sequencing or PCR-based techniques, next-generation sequencing (NGS) is a culture-free technique that allows investigation of the complete microbial community within a sample. 16S rRNA NGS permits microbiologists to accomplish genus-level sensitivity for metagenomic examinations of bacterial populations. The advantages of 16S rRNA Sequencing are driving the growth of the Metagenomics Market during the forecast period 2022-2027.

Metagenomics Market Challenges

Databases For Metagenomic Data Present Challenges To The Growth Of The Metagenomics Market:

Absorbing the sequence that will be produced by metagenomics projects will be demanding for the nucleic acid sequence data archive. Adding to the archiving challenge, it is evident that the community will need novel, secondary databases if the data are to be utilized efficiently. Only a specially-designed database will be able to provide constant storage and querying of the abundant metadata that metagenomic sequences require. The investigation of metagenomic sequences will need computational programs that are best provided in the context of a specially-designed database, for example, programs for the clustering of metagenomic sequence reads or for time-series analysis. And metagenomic data must be combined with data from distinct projects, like satellite data on ocean temperatures and time-series data on alterations in ocean salinity. This issue is hampering the growth of the Metagenomics Market.

Buy Now

Metagenomics Market Landscape:

Product launches, technological advancements, collaborations, mergers and acquisitions, financing in R&D activities, partnerships, and joint ventures are key strategies adopted by players in this Market. Metagenomics top 10 companies include:

Thermo Fisher Scientific, Inc.

QIAGEN

Illumina, Inc.

Promega Corporation

Novogene Co., Ltd.

Takara Bio, Inc

Oxford Nanopore Technologies

Arc Bio, LLC.

Eurofins Scientific

Zymo Research

Acquisitions/Product Launches:

In November 2021, QIAGEN declared the inclusion of StableScript™ to the OEM portfolio. The versatile reverse transcriptase is planned for application in one-step RT-qPCR and long-range RT-PCR and is accessible to order in bulk amounts. The launch of reverse transcriptases has permitted polymerase chain reaction (PCR) to be adapted to RNA and the establishment of cDNA libraries from mRNA.

In October 2021, QIAGEN N.V. declared the introduction and CE marking of QIAreach® QuantiFERON®-TB test for tuberculosis (TB) infection, to assist in accomplishing TB removal targets worldwide by boosting access to effortless and trustworthy TB testing, specifically in great burden countries, low-resource regions. A breakthrough in the battle against a pathogen estimated to be carried by over two billion people globally established on the proven QuantiFERON-TB Gold Plus technology, QIAreach® QuantiFERON®-TB is a portable instrument that allows the ultrasensitive digital discovery of TB infection with an end-to-end workflow that is clear and cost-efficient and raises access to trustworthy Interferon Gamma Release Assay (IGRA) testing. QIAGEN will target regions that encounter a huge burden of the ailment, and where procuring access to laboratory infrastructure and resources for testing is restricted.

In July 2021, QIAGEN N.V. declared the introduction of the Workflow Configurator, allowing researchers in the life sciences to effortlessly and speedily discover the best solutions to make their experiments perfect. Purchasers simply select their application, biological starting material, analyte, and analysis type. In seconds, the configurator arranges by way of hundreds of possible products to detect the most appropriate workflow and related products.